Log in to your account:
Insys Therapeutics (INSY) Jumps as Epinephrine Nasal Spray Shows Early Promise for Anaphylaxis
June 14, 2018 1:06 PM
INSYS Therapeutics, Inc. (NASDAQ: INSY) is gaining 18% intra-day after the company announced that its investigational epinephrine nasal spray showed ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intramuscular Injection
June 14, 2018 8:00 AM